fda warns hims & hers for selling unapproved compounded semaglutide The announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company to yank its new (Wegovy) weight-loss pill from the Hims to stop offering GLP-1
Pay in 4 interest-free payments of $5.76 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29



























